# POINT Biomedical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/point-biomedical

- Industry: Pharmaceuticals
- Headquarters: San Carlos, US
- Total disclosed funding: $38M
- Latest round: Series E (Jan 23, 2008)
- Investors on record: 13

## About

Founded in 1996, POINT Biomedical Corp., a pharmaceutical company, develops technologies for imaging and drug deliveries in the United States.

## Funding rounds

- Series E, Jan 23, 2008, $7M — CHL Medical Partners, Institutional Venture Partners, Invesco, Sprout Group, De Novo Ventures, SR One, Chicago Growth Partners, Vedanta Capital, New Leaf Venture Partners, Saratoga Ventures, Willowridge Partners
- Series E, Dec 28, 2007, $18M — Chicago Growth Partners, Vedanta Capital
- Series G, Jun 5, 2007, $4M — CHL Medical Partners, Institutional Venture Partners, Invesco, Chicago Growth Partners
- Series B, Nov 1, 1997, $9.3M — Frazier Healthcare Partners, Institutional Venture Partners, Sprout Group, Medicus Ventures

## Investors

- Frazier Healthcare Partners (https://capitalatlas.ai/funds/frazier-healthcare-partners) — Series B
- Institutional Venture Partners (https://capitalatlas.ai/funds/institutional-venture-partners) — Series B, Series G, Series E
- Sprout Group (https://capitalatlas.ai/funds/sprout-group) — Series B, Series E
- Medicus Ventures (https://capitalatlas.ai/funds/medicus-ventures) — Series B
- CHL Medical Partners (https://capitalatlas.ai/funds/chl-medical-partners) — Series G, Series E
- Invesco (https://capitalatlas.ai/funds/invesco) — Series G, Series E
- Chicago Growth Partners (https://capitalatlas.ai/funds/chicago-growth-partners) — Series G, Series E
- Vedanta Capital (https://capitalatlas.ai/funds/vedanta-capital) — Series E
- De Novo Ventures (https://capitalatlas.ai/funds/de-novo-ventures) — Series E
- SR One (https://capitalatlas.ai/funds/sr-one) — Series E
- New Leaf Venture Partners (https://capitalatlas.ai/funds/new-leaf-venture-partners) — Series E
- Saratoga Ventures (https://capitalatlas.ai/funds/saratoga-ventures) — Series E
- Willowridge Partners (https://capitalatlas.ai/funds/willowridge-partners) — Series E